Login / Signup

Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy.

Marta CasarrubiosMariano Provencio PullaErnest NadalAmelia InsaMaría Del Rosario García-CampeloMartín LázaroManuel DómineMargarita Majem TarruellaDelvys Rodríguez-AbreuAlex Martinez-MartiJavier De Castro CarpeñoManuel CoboGuillermo López-VivancoElvira Del BarcoReyes BernabéNuria ViñolasIsidoro Barneto ArandaBartomeu MassutiBelén Sierra-RoderoCristina Martinez-ToledoIsmael Fernández-MirandaRoberto Serna-BlancoAtocha RomeroVirginia CalvoAlberto Cruz-Bermúdez
Published in: Journal for immunotherapy of cancer (2022)
Our results reinforce the differences between CPR and non-CPR responses, describing possible response and relapse immune mechanisms, opening the possibility of therapy personalization of immunotherapy-based regimens in the neoadjuvant setting of NSCLC.
Keyphrases